iBio Inc (IBIO)

[Arthur Edward Whoof]

IBIO Technology, much more than a new med, this is a new method to produce meds with many advantages over existing methods

from IBIO's website-

The iBioLaunch™ platform is a proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins. The plants are easily and reliably scaled-up in low cost, controlled growth facilities to produce large amounts of recombinant protein in the plant biomass. The technology is highly flexible having the capability to produce both biotherapeutics and vaccines. Advantages of the whole plant approach include lower operating and capital expenses compared to protein production using engineered microbial or animal cells in bioreactors. The iBioLaunch platform offers significant advantages over earlier plant-based methods that rely on transgenic plants or plant cell cultures. These include the speed at which different proteins can be expressed and produced at commercial scale, which presents a significant commercial advantage, as well as public safety benefits when vaccines for pandemic diseases are required. Other advantages include scalability, no risks of contamination by animal pathogens, and the ability to express complex proteins at which other systems have failed.

the fact that ebola is in the headlines and IBIO has targeted their technology to this, it is only ONE of countless meds that this technology could be applied to

DOES ANYONE REALIZE THAT THIS IS WAY BIGGER THAN JUST EBOLA?

there is massive potential here in the pharm industry!